Posted by Michael Wonder on 30 Oct 2017
A new team aims to slash drug development time — with help from the feds
27 October 2017 - A global pharma company is teaming up with federal research labs and academics in an ambitious effort to slash the time spent screening potential cancer drugs before they make it into the clinic for testing.
The new consortium — dubbed Accelerating Therapeutics for Opportunities in Medicine, or ATOM — unveiled its plans on Friday, after a nearly two years of planning.
Its goal: To cut the pre-clinical development time from six years to one.
